Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
vendredi, octobre 02
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Senti Biosciences Holdings Inc
SNTI
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$0.3223
-0.0021
-0.65%
Dern. MÀJ: Oct 2, 9:16 AM
$0.3040
-0.0204
-6.29%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
Privacy Manager
Senti Biosciences Financials
Senti Biosciences (SNTI) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Senti Biosciences Q1 EPS $(0.14) Beats $(0.36) Estimate, Sales $16.000K
Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.36) by 61.11 percent. This is a 90.07 percent increase over losses of $(1.41) per share from
Benzinga Newsdesk
PRO
Senti Biosciences Q4 EPS $(0.53) Misses $(0.48) Estimate, Sales $22.000K Miss $666.667K Estimate
Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.48) by 11.11 percent. This is a 20.9 percent increase over losses of $(0.67) per share
Benzinga Newsdesk
PRO
Senti Biosciences Q3 EPS $(0.69) Misses $(0.56) Estimate
Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.56) by 23.21 percent. This is a 89.06 percent increase over losses of $(6.31) per share
Benzinga Newsdesk
PRO
Senti Biosciences Q2 EPS $(0.56) Beats $(0.90) Estimate
Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.90) by 37.78 percent. This is a 77.14 percent increase over losses of $(2.45) per share from
Benzinga Newsdesk
PRO
Senti Biosciences Q1 EPS $(1.41) Up From $(2.60) YoY
Benzinga Newsdesk
PRO
Senti Bio Sciences Q4 EPS ($0.67) Up From ($4.19) YoY.
Benzinga Newsdesk
